AI for Bio · Model

TranscriptFormer

CZI/Biohub cross-species generative single-cell model trained on about 110M cells from 12 species

Single-cell & perturbationNonprofit instituteUnited StatesActive中文

Overview

NameTranscriptFormer · aliases: TranscriptFormer, TF-Metazoa, TF-Exemplar, TF-Sapiens
Full nameThe name is itself the full name
Ambiguous names (not auto-linked)None
FamilyNot a family entry. Variants are treated as versions within one record
OrganizationChan Zuckerberg Initiative, Chan Zuckerberg Biohub
Organization typeNonprofit institute
CountryUnited States
Model classSingle-cell FM (generative)
DomainSingle-cell & perturbation
First release · paper revision
Basis: bioRxiv preprint posted (registry record) source
Other milestones
  • First public evidence: · bioRxiv preprint posted source
  • Preprint v1: · bioRxiv preprint v1 source
  • Journal online: · Science publication (registry record) source
Latest update · journal
Basis: Science publication
Journal version published in Science; GitHub v0.6.1 had been released on 2025-11-06 source
The most recent sourced event, not a claim that nothing changed since.
StatusActive · Journal paper and code release within 12 months
OpennessCode: Open · MIT
Weights: Open · MIT
Code and weights released via PyPI and a public data registry under MIT (from the registry page and a second-hand source)
Benchmarks reported0 counted · none of the 44
Wet-lab validationNone recorded
Unverified fields† open_status.weights_license, open_status.code_license
As of2026-11-17

What it does

Models each cell's transcriptome autoregressively as a "cell sentence", trained across 12 species; it supports cross-species cell-type transfer, zero-shot disease-state detection and generation of cell expression, with no perturbation evaluation. Unlike C2S-Scale, which turns expression into text and fine-tunes a general LLM, it is a dedicated single-cell autoregressive model.

Benchmarks reported

None of the 44 benchmarks. This model is on the zero-pairing list.

How it evaluates itself: Cross-species cell-type classification; Spermatogenesis cross-species mapping; Human cell type and disease state; Gene-gene and TF analyses

Other evaluations (outside the 44)

  • Cross-species cell-type classification (Own task set) Self-reported: Linear probes on 5 out-of-distribution species against UCE, ESM2-CE, scGPT and Geneformer; author-reported
  • Spermatogenesis cross-species mapping (Own task set) Self-reported: Label transfer across 9 vertebrate species; author-reported
  • Human cell type and disease state (Own task set) Self-reported: Tabula Sapiens 2.0 across 26 tissues plus infected vs uninfected lung cells; author-reported
  • scIB (Public benchmark not among the 44) Self-reported: Not a pairing: scIB-family data are used but no scIB metrics are reported
  • Gene-gene and TF analyses (Case study) Self-reported: Qualitative recovery of known interactions against STRING and cell-type TF prediction

Developers report: a generative model pretrained on about 112M cells from 12 species transfers cell-type labels across roughly 685 million years of divergence and detects disease states zero-shot, beating UCE and other baselines.

Independent evidence: No independent evidence found. No independent third-party evaluation of its cross-species results was found

Training data

Group in Figure 7: Public data only.

ClassValueDetail
a. Public databasesYesMainly CELLxGENE, about 112M cells across 12 species source
b. Private or licensed dataNo source
c. Own wet-lab data used for trainingNo source
d. Wet lab used only for validationNo

Wet-lab validation

None. The developers report no wet-lab validation.

Background

  • Organization: The Chan Zuckerberg Initiative is a philanthropy that in 2025-11 put Biohub at the centre of its biology and AI work, with CZI as supporting infrastructure; Biohub has sites in San Francisco, New York and Chicago, and the EvolutionaryScale team has joined it.
  • Funding: Founders' personal philanthropic funds; Biohub says it plans to reach 10,000 GPUs by 2028, with no AI-specific amount published.
  • Products and partnerships: TranscriptFormer is the first step of CZI's virtual-cell strategy; its data source CELLxGENE is shared with STATE, Stack and Tahoe-x1.
  • Related models: C2S-Scale, STATE, Stack, Tahoe-x1, scGPT / Geneformer

Reading notes

  1. With no scIB or perturbation scores, it cannot be compared directly with Geneformer, scGPT or STATE.
  2. Its strength is cross-species transfer, a task without a shared third-party board.
  3. Training is all public data, and its value for drug discovery is untested in the wet lab.

Caveats

  1. All evaluations are the authors' own task sets with no third-party reproduction.
  2. Site figures come from the bioRxiv text; the Science version is paywalled and takes precedence.
  3. Licence information partly comes from a second-hand source.

Sources

  1. Science paper (journal)
  2. bioRxiv preprint (preprint)
  3. Release list (repository)
  4. Package registry page (package registry)
  5. Public data registry page (official site)

Corrections

None recorded.

Part of the AI for Bio benchmarks survey · all 112 models · open in the explorer. Record as of 2026-11-17.